Literature DB >> 30373412

Birth population survey in Huai'an in 2015: perinatal-neonatal mortality and preterm birth rate in emerging regions in China.

H Wang7, H Yue1, B Sun2, X Zhu1, H Niu1, T Qi1, W Ding1, L Han1, M Zhang3, Z Tian3, H Guan4, J Yang4, S Li5, K Zhu5, C Tang6, M Dong6, Y Yin7, H Wang7, X Cao8, J Zhang8, H Liu9, Z Xu9, C Gao10, Y Heng10.   

Abstract

Objective: This survey followed the birth population-based study conducted in 2010 in Huai'an, Jiangsu Province, with the aim to estimate perinatal-neonatal mortality and preterm birth rate in emerging regions with similar maternal-fetal and neonatal care conditions in China.Materials and methods: Data of total births in 2015 were prospectively collected by regional perinatal network collaboration in Huai'an, a subprovincial region with a population of 5,644,500 and gross domestic production of 9082 USD per capita.
Results: The 59,424 birth registries (including 59,023 live births and 167 stillbirths) corresponded to a birth rate of 10.5‰ and a Male-to-female ratio of 113.7:100. All births there were from 85, 16, and 6 level I, II, and III hospitals, with a delivery rate of 30.4, 40.2, and 29.4%, respectively. Of all births, 14.1% had pregnancy-associated comorbidities and complications, 54.4% (32,226/59,190) had cesarean delivery, and multiple pregnancies and birth defects occurred in 2.1% (1,250) and 5.5‰ (324), respectively. The mean birth weight was 3448 ± 507 g with 13.9% being macrosomia, and 2.86% (1695/59,190) low birth weight. Preterm birth rate was 4.06% (2404/59,190) with a mortality rate of 8.5%. There were 94.5% recorded as healthy newborns and 5.5% (3263) requiring hospitalization after birth. The perinatal and neonatal mortality rate was 5.2‰ (167 stillbirths, 139 early neonatal deaths) and 4.0‰, respectively. Compared with the 2010 survey, these data demonstrated generally improved status of perinatal-neonatal healthcare.Conclusions: The low rates of perinatal-neonatal mortality, preterm birth and preterm mortality suggest that the concept and study protocol of perinatal-neonatal healthcare in Huai'an may serve as the benchmark for estimating regional vital statistics and perinatal and neonatal outcomes.

Entities:  

Keywords:  Birth defects; delivery; morbidity; mortality; neonate; perinatology; prematurity; stillbirth

Mesh:

Year:  2018        PMID: 30373412     DOI: 10.1080/14767058.2018.1506439

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  5 in total

1.  Incidence and trend of preterm birth in China, 1990-2016: a systematic review and meta-analysis.

Authors:  Shiwen Jing; Chang Chen; Yuexin Gan; Joshua Vogel; Jun Zhang
Journal:  BMJ Open       Date:  2020-12-12       Impact factor: 2.692

2.  A birth population-based survey of preterm morbidity and mortality by gestational age.

Authors:  Xiaojing Guo; Xiaoqiong Li; Tingting Qi; Zhaojun Pan; Xiaoqin Zhu; Hui Wang; Ying Dong; Hongni Yue; Bo Sun
Journal:  BMC Pregnancy Childbirth       Date:  2021-04-10       Impact factor: 3.007

3.  Perinatal Risks of Neonatal and Infant Mortalities in a Sub-provincial Region of China: A Livebirth Population-based Cohort Study.

Authors:  Yaling Xu; Xiaojing Guo; Zhaojun Pan; Guofang Zheng; Xiaoqiong Li; Tingting Qi; Xiaoqin Zhu; Hui Wang; Weijie Ding; Zhaofang Tian; Haijun Wang; Hongni Yue; Bo Sun
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-19       Impact factor: 3.105

4.  Outcome of neonatal hypoxemic respiratory failure: a livebirth population-based retrospective survey.

Authors:  Sufang Ding; Yaling Xu; Hui Wang; Hongni Yue; Zhaojun Pan; Bo Sun
Journal:  BMC Pediatr       Date:  2022-09-17       Impact factor: 2.567

5.  Stillbirths in China: a nationwide survey.

Authors:  J Zhu; J Zhang; H Xia; J Ge; X Ye; B Guo; M Liu; L Dai; L Zhang; L Chen; Y Wang; X Wang; H Liu; C Chen; Y Wang; G Wang; M Cai; X Yang; F Li; C Fan; Y Ruan; L Yu; R Zhang; H Xu; J Zhang; X Ma; D Yuan; Y Zhu; D Wang; A P Betran; H Qi; T Duan; J Zhang
Journal:  BJOG       Date:  2020-09-02       Impact factor: 6.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.